Where results make sense

About us   |   Why use us?   |   Reviews   |   PR   |   Contact us

Dr. Koop - Acute Myeloid Leukemia (Adult)- Health Encyclopedia and Reference Acute Myeloid Leukemia is the most common form of myeloid leukemia in adults (chronic lymphocytic leukemia is the most common form of leukemia in adults overall). In contrast, acute myeloid leukemia is an uncommon variant of leukemia in children. The median age at diagnosis of acute myeloid leukemia is 65 years of age, and approximately 9,000 individuals are affected by Acute Myelogenous Leukemia in the United States annually. www.drkoop.com /encyclopedia/93/640.html   (911 words)

Gleevec and Chronic Myeloid Leukemia - Cancer information on MedicineNet.com The development of Gleevec began in the early 1960s with the identification of the so-called Philadelphia chromosome (after the city in which it was identified) in patients with chronic myeloid leukemia. Chronic myeloid leukemia is characterized by a chronic (long duration) phase that is relatively benign. As a result of this acute phase, the average time of survival from chronic myeloid leukemia was about four years, meaning that half of the patients died before the four years and half were still alive at that time. www.medicinenet.com /script/main/art.asp?articlekey=17254   (1022 words)

Acute myeloid leukemia - WrongDiagnosis.com Acute myeloid leukemia (AML), also known as acute myelogenous leukemia, is a cancer of the myeloid line of white blood cells, characterized by the rapid proliferation of abnormal cells which accumulate in the bone marrow and interfere with the production of normal blood cells. With a diagnosis of Acute myeloid leukemia, it is also important to consider whether there is an underlying condition causing Acute myeloid leukemia. The prognosis of Acute myeloid leukemia may include the duration of Acute myeloid leukemia, chances of complications of Acute myeloid leukemia, probable outcomes, prospects for recovery, recovery period for Acute myeloid leukemia, survival rates, death rates, and other outcome possibilities in the overall prognosis of Acute myeloid leukemia. www.wrongdiagnosis.com /a/acute_myeloid_leukemia/intro.htm   (941 words)

Leukemia Diagnosis | Leukemia Chemotherapy | Treatments for Leukemia | Leukemia Treatment Advances in the treatment of adult acute myeloid leukemia (AML; also called acute nonlymphocytic leukemia or ANLL) have resulted in substantially improved complete remission rates.[1-5] Treatment should be sufficiently aggressive to achieve complete remission because partial remission offers no substantial survival benefit. Campos L, Rouault JP, Sabido O, et al.: High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Acute myeloid leukemia (AML) is classified morphologically according to the French-American-British criteria by the degree of differentiation along different cell lines and the extent of cell maturation.[1-3] www.meds.com /pdq/myeloid_pro.html   (7255 words)

Chronic Myeloid Leukaemia Myeloid cells are red blood cells, platelets and all other white cells except lymphocytes. Chronic myeloid leukaemia is a form of leukaemia that progresses slowly during the chronic phase of the disease. In chronic myeloid leukaemia the disease is typically widespread at the time of diagnosis, which is why this form of staging is not used. www.lrf.org.uk /en/1/infdispatcml.html   (5834 words)

Adult Acute Myeloid Leukemia Acute myeloid leukemia with inv(16)(p13q22) or t(16;16)(p13;q22); (CBFß/MYH11) This AML shows no evidence of myeloid differentiation by morphology and light microscopy cytochemistry.[54] The myeloid nature of the blasts is demonstrated by immunophenotyping and/or ultrastructural studies.[53] Immunophenotyping studies must be performed to distinguish this acute leukemia from acute lymphoblastic leukemia (ALL).[53] Cases of AML, minimally differentiated, comprise approximately 5% of cases of AML. The 2 subtypes of the acute erythroid leukemias, erythroleukemia and pure erythroid leukemia, are characterized by a predominant erythroid population and, in the case of erythroleukemia, the presence of a significant myeloid component. www.cancersource.com /Oncology/NCI/48,CDR0000062869   (11968 words)

Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies:   (Site not responding. Last check: 2007-10-09) Recurrent Childhood Acute Myeloid Leukemia and Juvenile Myelomonocytic Leukemia Childhood acute myeloid leukemia (AML) is a cancer of the blood and bone marrow. In childhood acute myeloid leukemia (AML), the subtype of AML and whether the leukemia has spread outside the blood and bone marrow are used, instead of the stage, to plan treatment. www.acor.org /cnet/258000.html   (4218 words)

Acute myeloid leukemia - Wikipedia, the free encyclopedia Acute myeloid leukemia (AML), which is also known as acute myelogenous leukemia, is a cancer of the myeloid line of white blood cells, characterized by the rapid proliferation of abnormal cells which accumulate in the bone marrow and interfere with the production of normal blood cells. The term "myeloid" was coined by Neumann in 1869, as he was the first to recognize that white blood cells were made in the bone marrow (Greek: µυєλός, myelos = (bone) marrow) as opposed to the spleen. "Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations". en.wikipedia.org /wiki/Acute_myeloid_leukemia   (4496 words)

Transcription Factors, Normal Myeloid Development, and Leukemia -- Tenen et al. 90 (2): 489 -- Blood To understand the process of normal myeloid differentiation, it is important to identify and characterize the transcription factors that specifically activate important genes in the myeloid lineage. An exciting prospect would be to use the myeloid regulatory elements to target given genes to proper hematopoietic compartments for gene therapy applications, particularly in terms of directing macrophage expression of enzymes involved in glycogen storage diseases. Myeloid promoter elements may be useful for viral vectors, especially adeno-associated virus (AAV), because, at least in transient assays, very small DNA fragments of a few hundred basepairs direct activity that is as high and as specific as much larger fragments. www.bloodjournal.org /cgi/content/full/90/2/489   (10740 words)

Acute Myeloid Leukemia (AML) Acute myeloid leukemia (AML), also known as acute myelogenous or acute myeloblastic leukemia, is a type of cancer that starts from cells that normally develop into blood cells. The Hutchinson Center is recognized as one of the leading centers involved in the research and treatment for acute myeloid leukemia (AML). In a study of 25 children with acute myeloid leukemia who relapsed after a first transplant, Hutchinson Center researchers found that nearly half of those who underwent a second transplant from a tissue-matched donor were still alive after 10 years. www.fhcrc.org /research/diseases/aml   (827 words)

Chronic Myeloid Leukemia (CML) Chronic myeloid leukemia (CML) is a disease in which too many immature white blood cells are made in the bone marrow. Chronic myeloid leukemia is distinguished from other types of leukemia by the presence of a genetic abnormality in blood cells called the Philadelphia chromosome. By determining the genes that may be associated with CML and developing tests to identify which of those genes are abnormal in an individual patient, doctors will be able to provide patients with the treatments most effective for their form of the disease. www.fhcrc.org /research/diseases/cml   (907 words)

Childhood acute myeloid leukemia and other childhood myeloid malignancies Juvenile myelomonocytic leukemia (JMML), formerly termed juvenile chronic myeloid leukemia (JCML), is a rare hematopoietic malignancy of childhood accounting for less than 1% of all childhood leukemias.[19] A number of clinical and laboratory features distinguish JMML from adult-type chronic myeloid leukemia, a disease noted only occasionally in children. JMML, formerly called juvenile chronic myeloid leukemia (JCML), is a rare leukemia that accounts for less than 1% of childhood leukemia cases.[15] JMML typically presents in young children (median age approximately 1 year) and occurs more commonly in boys (male to female ratio approximately 2.5:1). A major challenge in the treatment of children with acute myeloid leukemia (AML) is to prolong the duration of the initial remission with additional chemotherapy or bone marrow transplantation (BMT). cancerweb.ncl.ac.uk /cancernet/101081.html   (7288 words)

Acute Myeloid Leukaemia   (Site not responding. Last check: 2007-10-09) Acute Myeloid Leukaemia is a type of leukaemia which arises from the precursors of the myeloid cells which would subsequently, in normal circumstances, evolve into normal white cells. Acute Myeloid Leukaemia is uncommon and occurs at any time of life, with average incidence of acute myeloid leukaemia being 2.3 per 100,000 people per year. Acute Myeloid Leukaemiausually occurs (80%) in adults with the majority of cases of acute myeloid leukaemia occurring in people over the age of 60, with sex incidence being equal. www.virtualcancercentre.com /diseases.asp?did=439   (958 words)

The Forgotten Myeloproliferative Disorder: Myeloid Metaplasia -- Tefferi 8 (3): 225 -- The Oncologist Myelofibrosis with myeloid metaplasia is a hematologic disorder Pathogenesis of bone marrow fibrosis in myelofibrosis with myeloid metaplasia. In a retrospective study of 223 splenectomies performed in patients with myelofibrosis with myeloid metaplasia, the average spleen weight was 2.7 kilograms (range, 380 grams to 7.7 kilograms). theoncologist.alphamedpress.org /cgi/content/full/8/3/225   (2604 words)

Acute Myeloid Leukemia - Information The World Health Organization (WHO) classification of acute myeloid leukemia (AML) incorporates and interrelates morphology, cytogenetics, molecular genetics, and immunologic markers in an attempt to construct a classification that is universally applicable and prognostically valid. In the older French-American-British (FAB) criteria, the classification of AML is solely based upon morphology as determined by the degree of differentiation along different cell lines and the extent of cell maturation. Under the WHO classification, the category “acute myeloid leukemia not otherwise categorized” is morphology-based and reflects the FAB classification with a few significant modifications. acute-myeloid-leukemia.org   (869 words)

SEER Stat Fact Sheets - Acute Myeloid Leukemia From 2000-2003, the median age at diagnosis for acute myeloid leukemia was 67 years of age3. From 2000-2003, the median age at death for acute myeloid leukemia was 72 years of age4. Sometimes it is more useful to look at the probability of developing acute myeloid leukemia between two age groups. www.seer.cancer.gov /statfacts/html/amyl.html   (774 words)

Acute Myeloid Leukemia Information Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information. The term "myeloid" was coined by Neumann in 1869, as he was the first to recognize that white blood cells were made in the bone marrow (Greek: myelos) as opposed to the spleen. Acute myeloid leukemia is a curable disease; the chance of cure for a specific patient depends on a number of prognostic factors. acutemyeloidleukemia.researchtoday.net /about-acutemyeloidleukemia.htm   (4357 words)

Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies The myeloid leukemias in childhood represent a spectrum of hematopoietic malignancies. Schnittger S, Schoch C, Dugas M, et al.: Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Whitman SP, Archer KJ, Feng L, et al.: Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. www.meb.uni-bonn.de /cancer.gov/CDR0000062896.html   (14458 words)

Adult Acute Myeloid Leukemia Treatment - National Cancer Institute Advances in the treatment of AML (also called acute nonlymphocytic leukemia or ANLL) have resulted in substantially improved complete remission rates.[2] Treatment should be sufficiently aggressive to achieve complete remission because partial remission offers no substantial survival benefit. Kottaridis PD, Gale RE, Frew ME, et al.: The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Mrózek K, Prior TW, Edwards C, et al.: Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. www.cancer.gov /cancertopics/pdq/treatment/adultAML/healthprofessional   (929 words)

Acute Myeloid Leukemia Acute myeloid leukemia (AML) with inv(16)(p13q22), also known as M4Eo, is a distinct type of AML with a favorable prognosis associated with abnormal bone marrow eosinophils. Biphasic morphology in acute myeloid leukemia may be predictive of a near-tetraploid subclone and immunophenotypic transformation. However, podocalyxin was expressed by blasts in 30 (77%) of 39 cases of acute myeloid leukemia (AML), 22 (81%) of 27 cases of acute lymphoblastic leukemia (ALL), and 13 (87%) of 15 cases of cutaneous myeloid sarcoma. www.thedoctorsdoctor.com /diseases/leukemia_aml.htm   (6859 words)

Chronic Myeloid Leukemia Chronic myeloid leukemia (CML) is a leukemia which has been grouped in a category of blood diseases known as chronic myeloproliferative diseases. The t(8;21), which typically is associated with a distinct subtype of de novo acute myeloid leukemia (AML) carrying the aml1/eto fusion gene, was accompanied by increased bone marrow myeloblasts (33%) in case 1 and extramedullary myeloid sarcoma in case 2, suggesting its possible role in disease progression. VEGF was expressed in myeloid progenitors and megakaryocytes and less abundantly in mature granulomonocytic cells, whereas erythroid cells did not stain positively for VEGF. www.thedoctorsdoctor.com /diseases/leukemia_cml.htm   (3509 words)

Adult Acute Myeloid Leukemia - Cancer Overviews - GCC Adult acute myeloid leukemia (AML) is a disease in which cancerous cells develop in the blood and bone marrow. Adult acute myeloid leukemia affects the blasts that are developing into white blood cells called granulocytes. In adult acute myeloid leukemia, the blasts do not mature and become too numerous. www.umm.edu /cancer/overview/aml.html   (174 words)

NEJM -- Chronic Myeloid Leukemia   (Site not responding. Last check: 2007-10-09) Sessions, J. Monitoring your patients with chronic myeloid leukemia.. Huntly, B. P., Bench, A., Green, A. Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. Mohamed, A. N., Pemberton, P., Zonder, J., Schiffer, C. The Effect of Imatinib Mesylate on Patients with Philadelphia Chromosome-positive Chronic Myeloid Leukemia with Secondary Chromosomal Aberrations. content.nejm.org /cgi/content/short/340/17/1330   (3017 words)

eMedicine - Agnogenic Myeloid Metaplasia With Myelofibrosis : Article by Asheesh Lal, MBBS   (Site not responding. Last check: 2007-10-09) Clonality studies in patients with AMM demonstrate that myeloid cells arise from clonal stem cells; however, bone marrow fibroblasts and, sometimes, T cells are polyclonal. Extramedullary hematopoiesis in the spleen in a patient with agnogenic myeloid metaplasia. Jacobson RJ, Salo A, Fialkow PJ: Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. www.emedicine.com /med/topic78.htm   (5299 words)

Myeloid - Wikipedia, the free encyclopedia The term myeloid refers to a substance that originated in the bone marrow, or which resembles materials from the marrow. In describing hematopoiesis, the terms "myeloid" and "lymphoid" are often used to discriminate between cells originating from the marrow and from lymph tissue, respectively. This terminology is frequently seen when classifying cancers, especially leukemia. en.wikipedia.org /wiki/Myeloid   (117 words)

Mayo Clinic: Myelofibrosis with Myeloid Metaplasia - Information and treatment options at mayoclinic.org Myelofibrosis with myeloid metaplasia is a chronic form of leukemia. It causes secondary scarring or “fibrosis” in the bone marrow. The disease, also known as agnogenic myeloid metaplasia, may arise by itself or evolve from other myeloproliferative diseases (diseases that cause overproduction of blood cells in the bone marrow) such as essential thrombocythemia or polycythemia vera. www.mayoclinic.org /myelofibrosis   (341 words)

Agnogenic Myeloid Metaplasia   (Site not responding. Last check: 2007-10-09) Agnogenic Myeloid Metaplasia Agnogenic myeloid metaplasia (AMM, primary idiopathic myelofibrosis, myelosclerosis) is a clonal stem cell defect characterized by panmyelosis, progressive bone marrow fibrosis and splenomegaly. There is an equal incidence of agnogenic myeloid metaplasia in males and females. Acute leukemia, usually myeloid type (AML), develops in 10-20% of patients with agnogenic myeloid metaplasia. www.mcl.tulane.edu /classware/pathology/Krause/AMM/AMM.html   (260 words)

Childhood Acute Myeloid Leukemia Treatment - National Cancer Institute Treatment of newly diagnosed childhood acute myeloid leukemia (AML) is combination chemotherapy. Treatment of childhood acute myeloid leukemia (AML) during the remission phase (consolidation/intensification therapy) depends on the subtype of AML and may include the following: If the myelodysplastic syndrome progresses to acute myeloid leukemia (AML), treatment will be the same as treatment for the newly diagnosed patient with AML. www.cancer.gov /cancertopics/pdq/treatment/childAML/Patient/page5   (667 words)

Acute Myeloid Leukemia Treatment - Alternative Acute Myeloid Leukemia Treatment - Acute Nonlymphocytic Leukemia Acute myeloid leukemia (AML) is a cancer of cells in the blood, bone marrow and lymph nodes. In adult acute myeloid leukemia (AML), the subtype of AML and whether the leukemia has spread outside the blood and bone marrow are used instead of the stage to plan treatment. There are different types of treatment for patients with adult acute myeloid leukemia. www.apjohncancerinstitute.org /cancer/acutemy.htm   (6072 words)

Try your search on: Qwika (all wikis)

About us   |   Why use us?   |   Reviews   |   Press   |   Contact us   Copyright © 2005-2007 www.factbites.com Usage implies agreement with terms.